This is a program to bring down the cost of drugs for patients, and in doing so it is to save money across the board.

Our constituents are demanding action on high drug prices, and I am honored to serve on this committee.

It's important to note that there are no formularies in H.R. 3, and the issue of whether patients will have access to the medications that they need in Medicare--Medicare is going to continue to cover all of the drugs that it does today.

I think all the Members know that. You know that, certainly, and there is a big difference between capping out-of-pocket costs and the actual price of prescription drugs.

I think that we all need to take a deep breath and really roll our sleeves up and look for the opportunities to work together.

As a nation, we are paying three to four times more for these needed drugs than other countries.

H.R. 3 is written for patients. It's written for patients.

Many seniors have fixed incomes, with the majority of seniors living with incomes below $26,200.

a price should not be a death sentence.

The cost of prescription drugs is an enormous burden for the American people, and I think it's time for us to level the playing field for them.

H.R. 3 also ensures seniors can afford their out-of-pocket drug costs, bringing those costs down to $2,000 a year from as much as $5,100 a year or more.

We have a law in our country that prohibits Medicare from negotiating directly with drug companies--the only developed nation in the world with such a law.